A Clinical Study GK01 Injection in Subjects With Advanced Malignant Solid Tumors

by | Mar 19, 2026 | Clinical Trials | 0 comments

​ Conditions: Advanced Solid Tumors

Interventions: Drug: GK01 injection

Sponsors: Beijing Geekgene Technology Co., LTD; Peking University Cancer Hospital & Institute

Not yet recruiting Conditions: Advanced Solid Tumors
Interventions: Drug: GK01 injection
Sponsors: Beijing Geekgene Technology Co., LTD; Peking University Cancer Hospital & Institute
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *